Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.
Press Release – New York, NY – October 15, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).
MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions. MTBC received approximately $15 million in gross proceeds from the sale of 600,000 shares of Series A Preferred Stock sold to the public at a price of $25 per share for an aggregate offering amount of $15 Million. The series A Preferred Stock is traded on NASDAQ under the symbol "MTBCA." The offering is expected to close on or around October 15 2018, subject to the satisfaction of customary closing conditions.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Tom Rose and Jay Yamamoto.
Sichenzia Ross Ference LLP
Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF's renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021
Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021
Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd.
Sichenzia Ross Ference LLP Represents Zynex, Inc. in its $31.0 Million Acquisition of Kestrel Labs